英文名:5-[(4-Nitrobenzoyl)oxy]-2-[(2-pyrimidinylthio)meth
外观:
纯度:请咨询卖家
分子式:C17H11N3O6S
分子量:385.35
最小起售量:10g/20g/100g/1kg
英文名称:
5-[(4-Nitrobenzoyl)oxy]-2-[(2-pyrimidinylthio)methyl]-4H-pyran-4-one
英文同义词:
5-[(4-Nitrobenzoyl)oxy]-2-[(2-pyrimidinylthio)methyl]-4H-pyran-4-one;ML221;ML221; ML 221; ML-221;CS-2842;ML 221;ML-221;4H-Pyran-4-one, 5-[(4-nitrobenzoyl)oxy]-2-[(2-pyrimidinylthio)methyl]-;ML221 >=98% (HPLC)
沸点
624.1±55.0 °C(Predicted)
密度
1.54±0.1 g/cm3(Predicted)
溶解度
DMSO: soluble5mg/mL, clear (warmed)
酸度系数(pKa)
0.30±0.33(Predicted)
生物活性
ML221 是一种 apelin (APJ) 拮抗剂,抑制 apelin-13 介导的 APJ 的活化,在 cAMP 试验和 β-arrestin 实验中,IC50 值分别为 0.70 μM 和 1.75 μM,EC80 值均为 10 nM。
靶点
IC50: 1.75 μM (APJ, cell-based)
体外研究
ML221 is a potent apelin/APJ functional antagonist, inhibiting apelin-13-mediated activation of APJ, with IC 50 s of 0.70 μM in the cAMP assay, and 1.75 μM in the β-arrestin assay, and EC 80 of 10 nM in both assays. ML221 is >37-fold selective over the closely related angiotensin II type 1 (AT1) receptor (IC 50 , >79 μM) in cells. ML221 displays limited cross reactivity against a range of GPCRs except the κ-opioid and benzodiazepinone receptors (<50/<70%I at 10 μM).